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Abstract 
 
Background: High blood pressure (BP) is a risk factor for cardiovascular morbidity and 
mortality. While BP is regulated by the function of kidney, vasculature and sympathetic nervous 
system, recent experimental data suggest that immune cells may play a role in hypertension.  
Methods: We studied the relationship between major white blood cell types and blood pressure 
in the UK Biobank population and employed Mendelian randomization (MR) analyses using the 
∼750,000 UK-Biobank/International Consortium of Blood Pressure-Genome-Wide Association 
Studies to examine which leukocyte populations may be causally linked to BP. 
Results: A positive association between quintiles of lymphocyte, monocyte, neutrophil counts 
and increased systolic (SBP), diastolic (DBP) and pulse pressure (PP) was observed (e.g. 
adjusted SBP mean±SE for 1st vs 5th quintile respectively: 140.13±0.08 vs. 141.62±0.07 mmHg 
for lymphocyte, 139.51±0.08 vs. 141.84±0.07 mmHg for monocyte, and 137.96±0.08 vs. 
142.71±0.07 mmHg  for neutrophil counts, all p<10-50). Using 121 SNPs in MR implemented 
through the inverse-variance weighted (IVW) approach, we identified a potential causal 
relationship of lymphocyte count with SBP and DBP (causal estimates: 0.69 (95%CI: 0.19-1.20) 
and 0.56 (95%CI: 0.23-0.90) of mmHg per 1 SD genetically elevated lymphocyte count, 
respectively), which was directionally concordant to the observational findings. These IVW 
estimates were consistent with other, robust MR methods. Interestingly, the exclusion of 
rs3184504 SNP in the SH2B3 locus attenuated the magnitude of the signal in some of the MR 
analyses. MR in the reverse direction found evidence of positive effects of BP indices on counts 
of monocytes, neutrophils and eosinophils, but not lymphocytes or basophils. Subsequent MR 
testing of lymphocyte count in the context of genetic correlation with renal function or resting 
and post-exercise heart rate demonstrated a positive association of lymphocyte count with 
urinary albumin to creatinine ratio. 
Conclusions: Observational and genetic analyses demonstrate a concordant, positive and 
potentially causal relationship of lymphocyte count with SBP and DBP. 
 
Key Words: white blood cells; blood pressure; hypertension; mendelian randomization; LNK 
 
Nonstandard Abbreviations and Acronyms  
SBP/DBP=systolic/diastolic blood pressure 
PP=pulse pressure 
CHD=coronary heart disease 
GWAS=genome wide association study  
SNP=single nucleotide polymorphism 
MR=Mendelian randomization 
UKB=UK Biobank 
ICBP=International Consortium for Blood Pressure 
MAF=minor allele frequency 
IVW=Inverse-variance weighted  
HR=Heart Rate 
IV=Instrumental Variable 
GAM=Generalized Additive Model (GAM)  
GLM= General Linear Model 
UACR= Urinary Albumin-to-Creatinine Ratio 
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ATXN2=ataxin 2 
SH2B3= SH2B adaptor protein 3 
CKD = Chronic Kidney Disease 
eGFR= Estimated glomerular filtration rate 
 
Clinical Perspective 
 
What is new? 
• This cross-sectional and genetic study found potentially causal, positive effects of total 
blood lymphocyte count with blood pressure  
• Among mechanisms that might mediate this relationship, we found evidence that blood 
lymphocyte count might influence albuminuria 
• This study may additionally support a reverse, potentially causal positive effect of BP 
indices on blood neutrophil, monocyte and eosinophil counts 
 
What are the clinical implications? 
• High blood lymphocyte count may play a causal role in the development of hypertension 
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Introduction 
High blood pressure (BP) causes cardiovascular disease, including coronary heart disease (CHD) 
and stroke. While classical BP regulation is controlled by the function of kidney, vasculature and 
sympathetic nervous system, recent experimental data suggest that immune cells may play an 
important role in the development of hypertension 1-5. For example, immune cells infiltrating 
heart 6, perivascular adipose tissue or kidneys contribute to dysfunction of these organs and can 
mediate high BP 2. RAG1-/- mice 7 or rats 8, lacking functional T and B lymphocytes, are 
protected from experimental hypertension, and transfer of T lymphocytes restores the 
hypertensive phenotype 7. Moreover targeting B cells 9, monocytes and neutrophils as well as 
targeting inflammasome 10-13 shows their contribution to vessel remodeling and hypertension. 
While most data originate from experimental models, the relationships between white blood cells 
and hypertension remains poorly defined in humans. 
Well-powered, genome wide association studies (GWAS) have identified hundreds of 
single nucleotide polymorphisms (SNPs) associated with BP-related traits or circulating blood 
cell indices 14, 15. This creates an opportunity to test genetic, potentially causal relationships 
between these and other, clinically relevant cardiovascular traits using the Mendelian 
randomization (MR) approach. In brief, MR exploits characteristics of the human genome 
(principally its random allocation and non-modifiable nature) in order to make potentially causal 
deductions on the relationship of an exposure on a trait or disease 16. Indeed, previous studies 
employing such genetic approaches identified evidence in support of a causal relationship 
between white blood cell parameters such as lymphocytes and risk of CHD, making the 
exploration of the role of white blood cells in altering BP of particular interest 15. 
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In the present study, we studied the relationship between major white blood cell types and 
BP in the UK Biobank (UKB) population and employed MR analysis using data generated from 
large GWAS to examine whether leukocyte subpopulations may be causally linked to BP.  
 
Methods 
UKB data are available on application for data access (http://www.ukbiobank.ac.uk/). Data 
concerning SNPs used in MR analyses, linking white blood cell count and BP indices, are 
available in the supplemental excel file. GWAS summary statistics of the CKDGen consortium 
(http://ckdgen.imbi.uni-freiburg.de/), white blood cell counts 
(http://www.bloodcellgenetics.org/), HR phenotypes (https://www.cardiomics.net/download-
data, https://data.mendeley.com/datasets/tg5tvgm436/1) and BP indices (UKB+ICBP; 
https://www.ebi.ac.uk/gwas/downloads/summary-statistics) are available online. The ICBP 
GWAS summary statistics can be assessed through ICBP Consortium. 
Testing observational association between blood cell counts and BP indices 
UKB recruited 502 639 participants (aged 37–73 years) from 22 assessment centers across the 
UK between 2007 and 2010. Baseline biological measurements were recorded, and touch-screen 
questionnaires were administered, as described elsewhere 17. UKB received ethical approval 
from the North West Multi-Center Research Ethics Committee (11/NW/03820). All participants 
gave written informed consent before enrollment in the study, which was conducted in 
accordance with the principles of the Declaration of Helsinki. Using self-reported, ethnic 
background information we selected 442 604 white, British participants of the UK Biobank study 
to assess the effect of quintiles of circulating monocyte, lymphocyte, eosinophil, neutrophil and 
basophil counts on SBP, DBP and pulse pressure (PP) 17. Importantly, while blood cell indices 
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often correlate with each other (Suppl. Table 1), these 5 subpopulations were among 13, out of 
36, blood cell indices selected by Astle et al. as relatively independent and approximated all 
other white blood cell indices including absolute and percentage counts (e.g. blood neutrophil 
count strongly correlated with total white blood cell count and percentage of lymphocytes) 15, 18. 
Average of 2 automated, sitting BP readings (see online supplement for details regarding 
BP measurement procedure) was calculated and used in final analyses, and subjects with only 1 
reading available (9.2% for SBP or DBP) were excluded from further analyses, leaving 384,721 
subjects with available white blood cell counts for final analysis (table 1). Repeated blood 
pressure measurements were highly correlated 19. 
BP values from subjects on BP-lowering medications were adjusted in the same way as 
compared to GWAS on BP indices in the UKB and International Consortium for Blood Pressure 
(ICBP) 14, 20 i.e. by adding 15 and 10 mmHg to SBP and DBP, respectively 21 (see Suppl. Fig. 1 
for distribution of BP indices). We also performed separate sensitivity analyses after exclusion of 
subjects reporting BP-lowering medication use, using the same quintile boundaries as compared 
to the whole cohort. White blood cells were measured on fresh samples as an absolute number 
per unit volume, and their component leukocytes (lymphocytes, monocytes, neutrophils, 
eosinophils, and basophils) as absolute measures and proportions of the overall white blood cells; 
all using an automated, clinically validated, Coulter LH 750. Calibration and quality control were 
performed in line with the manufacturer’s recommendations 18. Further details of these 
measurements can be found in the UK Biobank online showcase and protocol 
(http://www.ukbiobank.ac.uk). While quintiles of monocyte, lymphocyte, eosinophil, and 
neutrophil counts contained on average 76 944±4588 subjects, quintiles of basophil count were 
less balanced, i.e. n=96 897  (all subjects with no basophils detected), 31 792, 128 937, 55 910, 
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and 77 185 subjects in the 1st, 2nd, 3rd, 4th and 5th quintile respectively (see Suppl. Fig. 2 for 
distributions of white blood cell counts). 
MR analyses testing causal effect of blood cell count on BP indices 
Instrumental variables 
We selected SNPs that associated with the level of circulating monocyte, lymphocyte, 
eosinophil, basophil or neutrophil counts at the genome-wide significance (P<8.31x10-9) in 
analysis of UKB and INTERVAL studies comprising 173 480 subjects 15. Final analyses 
included common (minor allele frequency (MAF)>5%) and uncorrelated (r2<0.2; validated in 
European British panel using LDlink 22) SNPs available in GWAS on outcome variables. 
Palindromic SNPs with a MAF>40% in the exposure GWAS, as well as SNPs from the MHC 
region (chr6:20 000 000-40 000 000, GRCh37), which likely possess pleiotropic effects, were 
excluded from analyses. 
Outcome variables 
Our primary analysis examined whether there exists a relation between 5 selected blood cell 
indices and SBP, DBP or PP based on genetic effect estimates published by Evangelou and 
colleagues in meta-analysis of two independent GWAS, i.e. UKB and ICBP, comprising 757 601 
subjects 14. We estimated that approximately 17.6% of subjects from the UKB+ICBP GWAS 14 
were also included in the GWAS on blood cell counts 15. Thus, in order to ensure that this 
overlap did not overly influence our results (e.g. due to overfitting or winner’s curse 16), a 
sensitivity analysis was performed using GWAS estimates derived solely from the ICBP 
consortium comprising 299 024 subjects 14. Of note, GWAS analysis on BP indices was adjusted 
for BMI 14, while GWAS analysis on blood cell counts was adjusted for log-height and log-
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weight, which implicitly adjusted for BMI 15 – thus both GWAS of exposures and outcomes 
adjusted for adiposity-related traits, potentially limiting confounding due to collider bias 23. 
A secondary analysis aimed to identify an intermediate phenotype which may mediate the 
causal effects, if present, of lymphocyte count on BP. Therefore, using published GWAS 
summary data, we selected traits, related to kidney and heart function, which have previously 
demonstrated a causal link to BP and/or hypertension through genetic analyses i.e. resting HR 24, 
increase in HR from resting level to peak exercise level and 25, eGFR assessed in subjects of 
European ancestry 26, and urinary albumin to creatinine ratio (UACR) derived from 2 different 
studies i.e. CKDGen consortium, and meta-analysis of the UK Biobank and CKDGen 
consortium 27, 28. All participants, included in the individual studies within CKDGen and ICBP 
consortia, provided written informed consent and studies were approved by their local Research 
Ethics Committees and/or Institutional Review Boards 20, 26-28. 
Reverse MR analyses 
We considered 885 SNPs replicated in 1-stage or 2-stage analyses in a GWAS on BP indices by 
Evangelou et al. 14. Among these, we selected 883 independent SNPs (r2<0.2 validated in 
European British panel using LDlink 22), and associated with SBP, DBP or PP at p<5x10-8 in the 
meta-analysis of UKB and ICBP consortia 14, and used these as IVs in an MR analysis on 5 
selected blood cell indices 15. Palindromic SNPs with a MAF>40% in the exposure GWAS, as 
well as SNPs from the MHC region were excluded from these analyses. 
Statistical analysis 
General linear model (GLM) in SPSS (ver. 25.0) was used to test the association of quintiles of 
cell counts on SBP, DBP and PP level while adjusting for sex, age, age squared, BMI, smoking 
status (3 categories: never-, former- and current), and alcohol intake frequency (6 categories: 
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never, special occasions only, one to three times a month, once or twice a week, three or four 
times a week, daily or almost daily). Quintile-specific estimated marginal means were reported 
and compared using ANOVA. In order to verify the observed associations, we performed similar 
analyses with additional adjustment for salt intake (Table 1) 1, 29 or using quantile regression 
using quantreg package in R (ver. 3.6.2) with the 3rd quintile set as a reference. In order to model 
the continuous relationship between blood cell counts and medication-adjusted BP indices 
quantile regression, Generalized Additive Model (GAM) using mgcv package (ver. 1.8-31) 30, 
and GLM analyses in R were used. Cubic regression spline smooth was applied to cell count 
parameters, and GAM analyses were additionally adjusted for BMI, age, age squared, sex, 
smoking status and alcohol intake frequency. 
Inverse-variance weighted (IVW) analyses were performed using 
MendelianRandomization package in R 31. Additional sensitivity analyses were performed using 
methods that are more robust to violations of MR assumptions, i.e. weighted median approach, 
allowing up to 50% of the weights to be invalid IVs 31, MR Egger method, which can include 
SNPs with pleiotropic effects that are not proportional to the effects of these SNPs on exposure 
16, 31, as well as Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO) 
method, which identifies and excludes SNPs that most likely display pleiotropic effects 32. 
Leave-one-out sensitivity analyses were performed using TwoSampleMR package in R 33. FDR-
based correction was applied to p values derived from MR analyses.  
  
 
D
ow
nloaded from
 http://ahajournals.org by on March 16, 2020
10.1161/CIRCULATIONAHA.119.045102 
10 
Results 
Levels of white blood cell subpopulations associate with BP in the UKB 
An association between quintiles of all cell types and SBP, DBP and PP was observed (Fig. 1). 
While the between-quintiles differences showed strong evidence of associations, even after 
Bonferroni correction for multiple testing, the association of blood neutrophil count with all 3 BP 
indices was relatively the strongest as compared to other white blood cells analysed (e.g. 
difference in adjusted SBP between the 5th and 1st quintile in mmHg (95% C.I.): 4.74 (4.47-5.01) 
for neutrophil, 2.33 (2.06-2.60) for monocyte, 1.49 (95% C.I. 1.22-1.76) for lymphocyte, 0.63 
(0.37-0.88) for basophil, and -0.95 (-1.21 - -0.69) for eosinophil counts; Fig. 1). This was further 
supported by analysis of continuously defined white blood cell counts (Suppl. Table 2). 
Interestingly the 1st quintile of eosinophil count was associated with higher SBP, and PP 
as compared to any other quintile (Fig. 1). Associations identified in the above observational 
analyses using GLM were confirmed using quantile regression analysis (Suppl. Table 3), after 
exclusion of subjects on BP-lowering medication (Suppl. Fig. 3), or after additional adjustment 
for salt intake (Suppl. Fig. 4). GAM analyses identified evidence (at p<5x10-4) of smooth terms 
of all analysed blood cell counts on SBP, DBP and PP. In particular, count of monocytes and 
neutrophils was associated with SBP in a dose-dependent manner (Suppl. Fig. 5), while positive 
effect of lymphocytes on SBP could be observed above the 2nd quintile of lymphocyte count 
(Suppl. Fig. 5). Additionally, GAM analyses confirmed protective effect of higher eosinophil 
count on all BP indices (Suppl. Fig. 5). 
MR analysis of white blood cell counts and blood pressure indices 
We next sought to investigate causal relationships between major white blood cell counts and BP 
indices using 121, 87, 146 (147 for DBP analysis), 126 (127 for DBP analysis) and 50 
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uncorrelated SNPs used as IVs for analysis of total lymphocyte, neutrophil, monocyte, 
eosinophil and basophil count respectively (see supplemental excel file for a list of all SNPs used 
as IVs). 
We identified positive, potential causal relationships between lymphocyte count with 
SBP and DBP, concordant in all analytical approaches (Figure 2 and Suppl. Table 4). In 
particular, after FDR correction for multiple testing, IVW and MR-PRESSO methods 
demonstrated a potential causal relationship between lymphocyte count and both BP indices 
(with a 1 SD genetically instrumented higher lymphocyte count leading to a 0.69 mmHg 
(95%CI: 0.19-1.20) higher SBP; P=0.007 and 0.56 mmHg (95%CI: 0.23-0.90) higher DBP; 
P=0.001), with findings similar when using robust MR approaches, including MR-Egger and 
weighted median methods (Figure 2 and Suppl. Table 4). Importantly, using ICBP-only data 
(with no participant overlap), we demonstrated consistent, positive effects between total 
lymphocyte count and both SBP and DBP using all 4 analytical methods (Suppl. Table 5). 
Interestingly, all MR analytical approaches demonstrated relationship between total 
eosinophil count and higher DBP level (Figure 2 and Suppl. Table 4), and this finding was 
replicated using BP estimates derived from only the ICBP consortium (Suppl. Table 5). Of note, 
MR-Egger found relatively strong evidence for pleiotropy (Suppl. Table 4 and 5) and causal 
effects were in the opposite direction as compared to the observational findings (Fig. 1). No 
association concerning total neutrophil, monocyte or basophil counts, observed in the primary 
analysis using UKB+ICBP BP estimates (Figure 2 and Suppl. Table 4), could be replicated using 
ICBP-only data at a nominal significance threshold (Suppl. Table 5). 
Inspection of scatter plots, visualizing the associations of individual SNPs (used as IVs) 
with BP indices and lymphocyte or eosinophil counts, as well as leave-one-out sensitivity 
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analyses identified a single variant in the ATXN2/SH2B3 locus that influenced the IVW 
association (Suppl. Fig. 6 and 7). Exclusion of these variants from MR analyses on lymphocyte 
count (rs3184504) or eosinophil count (rs653178) attenuated the causal estimates (Fig. 3). In this 
scenario (i.e. on excluding rs653178), the relationship of eosinophil count with SBP attenuated, 
while the magnitude of the positive association of lymphocyte count with SBP (weighted median 
and MR-PRESSO methods) or DBP (IVW and MR-PRESSO methods; Fig. 3) was reduced. 
Reverse MR analysis assessing the impact of BP on blood cell counts 
In order to further understand a source of observational associations between BP and blood cell 
counts, we used BP-associated variants as IVs to explore the relationship of BP traits with blood 
cell traits in the reverse direction. We found no evidence of association between any of the BP 
index and lymphocyte or basophil count (Figure 4 and Suppl. Table. 6; see supplemental excel 
file for a list of all SNPs used as IVs). Of interest, MR analyses supported the existence of 
positive effects of SBP and DBP on monocyte and eosinophil count, while positive effects of 
SBP and PP were identified for neutrophil count (Figure 4 and Suppl. Table. 6). Inspection of 
scatter plots, visualizing effects of all individual IVs on cell counts and BP indices, as well as 
leave-one-out sensitivity analyses found that while rs3184504 SNP in SH2B3 inflated the IVW 
causal estimates for neutrophil, monocyte and eosinophil counts, the estimates remained robust 
to exclusion of this particular SNP (Suppl. Fig. 8 and 9). 
Renal function and heart rate in the context of the circulating lymphocyte counts 
Primary observational association and genetic analyses demonstrated concordant effect 
directions of lymphocyte count on SBP, and DBP. Thus, we tested lymphocyte counts in the 
context of genetic correlation with kidney function, and heart rate parameters. An evidence of 
positive association was found between level of circulating lymphocytes and UACR using MR-
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PRESSO and IVW (Suppl. Table 7), but not other methods (Suppl. Table 7). No association 
between level of circulating lymphocytes and resting HR, increase in HR from resting level to 
peak exercise level, and eGFR was identified (Suppl. Table 7). Inspection of scatter plots, 
visualizing effects of all IVs on lymphocyte count and UACR, as well as leave-one-out 
sensitivity analyses found that IVW causal estimates remained robust to exclusion of any single 
SNP from MR analysis (Suppl. Fig. 10 and 11). 
 
Discussion 
Using a Mendelian randomization approach, the current study identified a positive, potentially 
causal relationship between circulating blood lymphocyte counts and BP levels. This is of 
importance given findings reported in a recent study that identified evidence in support of a 
causal relationship between circulating lymphocytes and risk of CHD 15. Although the genetic 
effect of lymphocyte count on CHD reported in previous studies was, at least partially, driven by 
variants in the MHC locus 15, our study provides a plausible mechanism by which lymphocytes 
might cause CHD– through increases in BP parameters. Of note, our MR analysis identified a 
potential causal relationship between total lymphocyte count and both SBP and DBP that was 
independent of MHC region. This is of importance because SBP and DBP are recognised causal 
risk factors for cardiovascular disease 34. 
The MR concept has been widely utilized to elucidate potential causal relationships 
between various risk factors and disease outcomes. Using this approach, it has been shown that 
myeloid and lymphoid blood cell counts are causally related to several autoimmune diseases, yet 
not to chronic kidney disease (CKD) or type 2 diabetes mellitus 15. MR analysis has been also 
used to make causal inference in the pathogenesis of hypertension. For example, lower eGFR 
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causally influences DBP and hypertension 35. A recent study on urinary biomarkers in the UKB 
identified genetic correlation between SBP and four parameters reflecting renal function, 
including UACR 36. Moreover, genetic risk scores of resting HR or HR response to exercise are 
associated with BP 24, 25, while genetic determinants of brachial artery diameter 37, associate with 
BP as well 14. These results, derived from GWAS, support a key role of kidney in the regulation 
of BP and suggest a tight relation between BP and function of sympathetic nervous system, 
controlling HR, and vasculature.  
Interestingly, while neutrophil count appeared to be the strongest component of white 
blood cells associated with SBP and DBP in an observational analysis in the UKB, we did not 
identify evidence of a causal effect on these BP indices in MR analysis. This may indicate 
confounding of the observational analysis, reverse causation, which was, at least partially, 
identified in the current study, or more acute effects of neutrophil count on BP that might not be 
captured by MR analysis. Indeed data from the CANTOS trial, which investigated the use of 
canakinimab, an IL-1β blocker, in CVD prevention, demonstrated that although the studied drug 
was profoundly neutropenic 38, 39, it had no effect on BP 40, yet it should be emphasized that this 
was not a specific, neutrophil-targeting intervention. Inflammation may cause cardiovascular 
disease through a myriad of pathways, and BP is only one potential component of this. 
Our data are important as they provide mechanistic context to observational associations 
that earlier studies have reported, indicating a relationship between peripheral blood lymphocytes 
and hypertension. In our previous studies we have identified that hypertensive patients are 
characterized by increased central memory, Th17 as well as IFN- producing immunosenescent 
or effector CD8+ cells 41, 42. Moreover, circulating lymphocytes have been associated with 
microvascular remodelling in hypertension 43. At the same time, we have recently observed 
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relationships between monocyte subpopulations and hypertension 44. Our current data, which 
include bidirectional assessment of genetic association between BP and blood cell counts, help to 
interpret these and may indicate that increases in monocytes with increasing blood pressure, are, 
similarly to neutrophils, most likely a consequence rather than a cause of hypertension.  
The mechanism by which white blood cells, and especially lymphocytes, may cause 
hypertension remains unclear. Experimental animal data suggest that the effects of lymphocytes 
might be mediated by modulating vascular function, sympathetic outflow and hypertension as 
well as renal sodium reabsorption and salt handling by antigen presenting cells 1-3, 5, 29. Using 
available, large-scale GWAS, we aimed to identify a target organ, whose function is causal to BP 
and might be affected by lymphocyte count. Interestingly, our analysis of phenotypes related to 
kidney, and sympathetic nervous system function demonstrated that genetically defined, higher 
total lymphocyte count related to a higher UACR using MR-PRESSO and IVW analyses, yet the 
associations were weaker using other analytical approaches. On the other hand, association 
between lymphocyte count and UACR could be observed using UACR data derived from 2 
different studies 27, 28, which may support a causal link between lymphocyte count and 
albuminuria. Furthermore, this may indicate that lymphocytes affect BP via UACR, yet it might 
be as well that lymphocytes affect UACR through independent causal pathways that might 
include BP. Interestingly, recent studies indicate that a bidirectional association between 
albuminuria and BP exists 45. Moreover, while genetic liability to albuminuria associates with 
hypertension and, further with stroke and heart failure, it does not associate with CKD 45, which 
may explain the lack of a causal relationship between lymphocyte count and eGFR in the current 
study. Consequently, it has been proposed that albuminuria may have tubular origins due to 
sodium retention in the distal tubule 46. 
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Other than the analyses of the genetic correlation between lymphocyte count and UACR, 
important biological information can be obtained while selecting genes in proximity to SNPs that 
associate with both lymphocyte count and BP indices in the concordant direction (Suppl. Table 
8). Many genes, whose function may be affected by selected SNPs, have been investigated in the 
context of BP regulation in vivo, and previous studies linking genetics of hypertension to 
lymphocyte biology focused on SH2B3 as top key driver for hypertension (Suppl. Table 8). For 
example, an in vivo study demonstrated exacerbated hypertension, vascular dysfunction and 
infiltration of IFN-producing CD8+ T cells in response to AngII in Sh2b3 knockout animals as 
compared to wild type mice 47. SNP rs3184504 is a missense mutation within SH2B3 and leads 
to an R262W amino acid change in Lnk 48, which is a negative regulator of haematopoiesis and 
TNFα signaling in endothelial cells and may play a role in integrin signalling 49. Interestingly, 
SH2B3 locus has been associated with various cardiovascular-related traits and diseases, 
including CHD 50, and its effect on blood pressure may be at least partially mediated by 
influencing β-2 microglobulin levels in humans 51. This suggests potentially pleiotropic effect of 
SH2B3 on blood pressure level. Of importance, sensitivity analyses performed in the present 
study, identified rs3184504 SNP in SH2B3 as a potential pleiotropic outlier, and its exclusion led 
to attenuation of the MR relationships calculated by all analytical approaches. However, after 
exclusion of rs3184504 SNP, evidence of potential causal effect of lymphocyte count on BP was 
retained in IVW, weighted median or MR-PRESSO analytical approaches. 
The interpretation of estimates derived from MR can be challenging 52. Notwithstanding 
this, MR relies on assumptions that may be untestable (e.g. exclusion restriction, especially in the 
presence of unknown/unmeasured potential confounding) 53. For example, horizontal pleiotropy, 
the phenomenon where genetic variants independently associate with traits other than the ones 
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under investigation, can lead to confounding of the MR estimates. The susceptibility of the 
estimates derived from MR to such horizontal pleiotropy can be investigated through the 
application of sensitivity analyses that are more robust to such types of pleiotropy as performed 
in the current study e.g. MR-Egger and weighted median approaches 16. While none of these 
methods when individually used entirely protects the findings from MR from the influence of 
potential pleiotropic effects, a consistency of effect estimates derived across multiple sensitivity 
analyses adds confidence to the plausibility of the presence of a true underlying causal effect. 
Other forms of confounding in MR exist, such as population structure 53. In the current analysis, 
GWAS used in the identification of white blood cell counts and BP indices used methodology 
that takes into account cryptic relatedness and population stratification 14, 15, which should 
minimise the potential for such sources of confounding. A further vulnerability is the potential 
for overfitting 54 in the context of the same dataset used for discovery (i.e. GWAS) and MR. To 
avoid the potential for such, we used ICBP GWAS on BP indices 14, characterized by no subjects 
overlapping with the GWAS on white blood cell counts, in order to confirm lack of overfitting of 
the effects of genetically defined blood lymphocyte count on SBP and DBP level. 
In contrast to MR analyses, our observational results are likely to be more susceptible to 
errors induced by confounding or reverse causation phenomena. While the associations of white 
blood cell counts with BP seem to be independent of commonly used potential confounders such 
as sex, age, BMI, salt/alcohol intake or smoking habits, we cannot exclude the existence of 
residual confounding, e.g. by variables influencing blood cell count-BP association. The reverse-
causation phenomenon is, by definition, not feasible to address in the context of cross-sectional 
data, thus motivating the need for either prospective studies with comprehensive follow-up 
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and/or approaches were reverse causation cannot be a phenomenon, such as MR approach or 
randomized controlled trials. 
In summary, the current study identified evidence in support of a potential causal link 
between elevated lymphocyte count and higher BP. The molecular mechanism of this association 
is possibly independent of the classical regulatory mechanisms related to kidney function or 
heart rate, but might involve pathways related to albuminuria. Furthermore, results of reverse 
MR analyses may support potential causal, effects of increased BP on higher levels of blood 
neutrophil, monocyte and eosinophil but not lymphocyte or basophil counts. 
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Table 1. Characteristics of 384,721 white, British participants from the UK Biobank study who 
were included in the analysis 
 
Males, n (%) 177,322 (46.1) 
Age in years, mean (SD) 56.88 (7.99) 
BMI in kg/m2, mean (SD) 27.37 (4.72) 
SBP in mmHg, mean (SD) 138.12 (18.58) 
DBP in mmHg, mean (SD) 82.21 (10.08) 
PP in mmHg, mean (SD) 55.91 (13.62) 
Lymphocyte count in 106 cells/ml, median (IQR) 1.86 (1.50-2.28) 
Neutrophil count in 106 cells/ml, median (IQR) 4.05 (3.30-4.99) 
Monocyte count in 106 cells/ml, median (IQR) 0.45 (0.37-0.57) 
Eosinophil count in 106 cells/ml, median (IQR) 0.14 (0.10-0.21) 
Basophil count in 106 cells/ml, median (IQR) 0.02 (0.00-0.04) 
Smoking status, n (%) 
Never smoker 
Previous smoker 
Current smoker 
 
208,606 (54.4) 
135,988 (35.5) 
38,782 (10.1) 
Alcohol intake frequency, n (%) 
Daily or almost daily 
Three or four times a week 
Once or twice a week 
One to three times a month 
Special occasions only 
Never 
 
81,946 (21.3) 
92,342 (24.0) 
101,370 (26.4) 
42,678 (11.1) 
40,900 (10.6) 
25,222 (6.6) 
Salt intake (salt added to food), n (%) 
Never/rarely 
Sometimes 
Usually 
Always 
 
218,726 (56.9) 
106,037 (27.6) 
43,212 (11.2) 
16,707 (4.3) 
Use of BP-lowering medications, n (%) 79,719 (20.7) 
SBP/DBP=systolic/diastolic blood pressure, BMI=body mass index, IQR=inter-quartile range 
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Figure Legends 
 
Figure 1. Levels of five white blood cell types are associated with systolic (SBP), diastolic 
blood pressure (DBP) and pulse pressure (PP) in the UK Biobank. Estimated marginal means 
of blood pressure (BP) indices, from general linear model analysis adjusted for sex, age, age 
squared, body mass index (BMI), smoking status and alcohol intake frequency, are presented 
according to quintiles of counts of white blood cell subpopulations. All ANOVA tests, assessing 
global between-quintiles differences in BP indices were significant at p<10-11. Post-hoc tests 
revealed that all comparisons between the 1st and the 5th quintile of any cell type count with 
respect to any BP index were significant at Bonferroni corrected p<0.05, given 150 tests (5 types 
of blood cell counts x 3 BP indices x 10 between-quintile differences) performed. 
 
Figure 2. Mendelian Randomization (MR) analyses testing the effects of five white blood 
cell subpopulation counts on systolic blood pressure (SBP), diastolic blood pressure (DBP) 
and pulse pressure (PP). Results obtained using four MR methods (Inverse-variance weighted - 
IVW; MR-Egger;  Weighted Median and MR-PRESSO) are presented as heatmap representing 
causal estimates (1SD of BP index per 1SD of cell count ) *FDR p<0.05 for particular MR 
approach 
 
Figure 3. Mendelian Randomization (MR) analyses testing effect of lymphocyte or 
eosinophil counts on systolic (SBP) and diastolic (DBP) blood pressure levels, before and 
after exclusion of a single variant from the SH2B adaptor protein 3/ataxin 2 
(SH2B3/ATXN2) locus. Results of four MR methods (Inverse-variance weighted - IVW; MR-
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Egger;  Weighted Median and MR-PRESSO) are presented as causal estimates with 95% 
confidence intervals (95% C.I.). 
 
Figure 4. Reverse Mendelian Randomization (MR) analyses testing the effects of systolic 
blood pressure (SBP), diastolic blood pressure (DBP) and pulse pressure (PP) on cell 
counts of white blood cell subpopulations. Results obtained using four MR methods (Inverse-
variance weighted - IVW; MR-Egger; Weighted Median and MR-PRESSO)  are presented as 
heatmap representing causal estimates (1SD cell count per 1SD BP index); SD=Standard 
Deviation; *FDR p<0.05 for particular MR approach; 
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